Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

44 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Eltrombopag for children with chronic immune thrombocytopenia (PETIT2): a randomised, multicentre, placebo-controlled trial.
Grainger JD, Locatelli F, Chotsampancharoen T, Donyush E, Pongtanakul B, Komvilaisak P, Sosothikul D, Drelichman G, Sirachainan N, Holzhauer S, Lebedev V, Lemons R, Pospisilova D, Ramenghi U, Bussel JB, Bakshi KK, Iyengar M, Chan GW, Chagin KD, Theodore D, Marcello LM, Bailey CK. Grainger JD, et al. Among authors: chotsampancharoen t. Lancet. 2015 Oct 24;386(10004):1649-58. doi: 10.1016/S0140-6736(15)61107-2. Epub 2015 Jul 28. Lancet. 2015. PMID: 26231455 Clinical Trial.
Clinical outcomes and prognostic factors to predict treatment response in high risk neuroblastoma patients receiving topotecan and cyclophosphamide containing induction regimen: a prospective multicenter study.
Rujkijyanont P, Photia A, Traivaree C, Monsereenusorn C, Anurathapan U, Seksarn P, Sosothikul D, Techavichit P, Sanpakit K, Phuakpet K, Wiangnon S, Chotsampancharoen T, Chainansamit SO, Kanjanapongkul S, Meekaewkunchorn A, Hongeng S. Rujkijyanont P, et al. Among authors: chotsampancharoen t. BMC Cancer. 2019 Oct 16;19(1):961. doi: 10.1186/s12885-019-6186-z. BMC Cancer. 2019. PMID: 31619207 Free PMC article.
Pediatric primary central nervous system tumors registry in Thailand under National Health Security Office schemes.
Pongtanakul B, Sirachainan N, Surapolchai P, Charoenkwan P, Choeyprasert W, Komwilaisak P, Chainansamit SO, Witsanuyothin N, Lertrakul Y, Rujkijyanont P, Kanjanapongkul S, Sosothikul D, Sanpakit K, Chotsampancharoen T, Wangruangsathit S, Thokanit NS, Tabjareon S, Hongeng S. Pongtanakul B, et al. Among authors: chotsampancharoen t. J Neurooncol. 2020 Aug;149(1):141-151. doi: 10.1007/s11060-020-03582-w. Epub 2020 Jul 24. J Neurooncol. 2020. PMID: 32710301
Treatment outcomes of high-dose chemotherapy plus stem cell rescue in high-risk neuroblastoma patients in Thailand.
Suwannaying K, Techavichit P, Komvilaisak P, Laoaroon N, Narkbunnam N, Sanpakit K, Chiengthong K, Chotsampancharoen T, Sathitsamitphong L, Santong C, Seksarn P, Hongeng S, Wiangnon S. Suwannaying K, et al. Among authors: chotsampancharoen t. Clin Exp Pediatr. 2022 Sep;65(9):453-458. doi: 10.3345/cep.2022.00437. Epub 2022 May 24. Clin Exp Pediatr. 2022. PMID: 35619231 Free PMC article.
Treatment outcomes among high-risk neuroblastoma patients receiving non-immunotherapy regimen: Multicenter study on behalf of the Thai Pediatric Oncology Group.
Suwannaying K, Monsereenusorn C, Rujkijyanont P, Techavichit P, Phuakpet K, Pongphitcha P, Chainansamit SO, Chotsampancharoen T, Winaichatsak A, Traivaree C, Sathitsamitphong L, Kanjanapongkul S, Komvilaisak P, Sanpakit K, Photia A, Seksarn P, Wiangnon S, Hongeng S; Thai Pediatric Oncology Neuroblastoma Working Group. Suwannaying K, et al. Among authors: chotsampancharoen t. Pediatr Blood Cancer. 2022 Sep;69(9):e29757. doi: 10.1002/pbc.29757. Epub 2022 May 13. Pediatr Blood Cancer. 2022. PMID: 35560972
44 results